Valuation Mega Lifesciences Thailand S.E.

Stocks

End-of-day quote Thailand S.E. 2026-09-11			5-day change	1st Jan Change
36.50 ^THB	+2.10%		+1.39%	+8.96%

08-24	Mega Lifesciences Public Company Limited, Q2 2026 Earnings Call, Aug 14, 2026
08-13	Mega Lifesciences Public Company Limited Announces Declaration of Interim Dividend for Period from 01 January 2026 to 30 June 2026, Payable on 11 September 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	44,029	40,760	35,093	28,990	29,208	31,823	-	-
Change	-	-7.43%	-13.9%	-17.39%	0.75%	8.96%	-	-
Enterprise Value (EV) ¹	41,666	38,309	32,456	25,464	25,051	27,207	27,103	26,770
Change	-	-8.06%	-15.28%	-21.54%	-1.62%	8.6%	-0.38%	-1.23%
P/E	22.6x	18.2x	17.6x	14.4x	15.3x	13.5x	12.8x	12x
PBR	5.5x	4.64x	3.77x	2.94x	2.86x	2.99x	2.87x	2.76x
PEG	-	1.2x	-1.6x	16.49x	-2.95x	0.6x	2.45x	1.81x
Capitalization / Revenue	3.08x	2.6x	2.24x	1.89x	2.06x	2.22x	2.03x	1.93x
EV / Revenue	2.91x	2.44x	2.07x	1.66x	1.77x	1.9x	1.73x	1.63x
EV / EBITDA	17.2x	13x	10.2x	6.78x	8.73x	8.64x	7.68x	7.13x
EV / EBIT	18.1x	14.3x	11.2x	7.56x	9.69x	9.9x	8.52x	7.91x
EV / FCF	16.2x	22.6x	19.6x	11.8x	11.9x	13.2x	12.4x	11.9x
FCF Yield	6.18%	4.42%	5.09%	8.46%	8.41%	7.58%	8.06%	8.42%
Dividend per Share ²	1.06	1.61	1.65	1.6	1.6	1.76	1.897	2.021
Rate of return	2.1%	3.44%	4.1%	4.81%	4.78%	4.82%	5.2%	5.54%
EPS ²	2.23	2.57	2.29	2.31	2.19	2.71	2.851	3.04
Distribution rate	47.5%	62.6%	72.1%	69.3%	73.1%	64.9%	66.5%	66.5%
Net sales ¹	14,301	15,686	15,681	15,344	14,147	14,347	15,664	16,457
EBITDA ¹	2,426	2,953	3,190	3,756	2,868	3,150	3,529	3,756
EBIT ¹	2,305	2,681	2,904	3,370	2,585	2,748	3,180	3,383
Net income ¹	1,947	2,242	1,993	2,012	1,912	2,231	2,485	2,652
Net Debt ¹	-2,363	-2,451	-2,636	-3,525	-4,156	-4,617	-4,720	-5,053
Reference price ²	50.50	46.75	40.25	33.25	33.50	36.50	36.50	36.50
Nbr of stocks (in thousands)	871,870	871,870	871,870	871,870	871,870	871,870	-	-
Announcement Date	2/23/22	2/25/23	2/22/24	2/24/25	2/24/26	-	-	-

¹THB in Million²THB

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	31.77x	11.54x	23.41x	0.62%	994B
JOHNSON & JOHNSON	29.54x	-	-	2.02%	640B
ABBVIE INC.	32.92x	7.63x	15.78x	2.67%	454B
ROCHE HOLDING AG	18.71x	4.57x	11.31x	2.91%	337B
NOVARTIS AG	19.41x	5.08x	12.59x	3.21%	261B
ASTRAZENECA PLC	20.34x	4.19x	11.96x	2.11%	246B
AMGEN INC.	23.87x	6.3x	11.23x	2.67%	204B
NOVO NORDISK A/S	12.3x	4.48x	9.37x	4.08%	190B
GILEAD SCIENCES, INC.	-43.47x	6.35x	24.81x	2.29%	178B
Average	16.16x	6.27x	15.06x	2.51%	389.42B
Weighted average by Cap.	23.19x	7.72x	17.10x	2.05%